Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Perindopril erbumine
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Perindopril erbumine 8mg tablets
0205051M0AAAFAF
|
Perindopril erbumine | Perindopril erbumine | Cardiovascular System | 261,976 |
|
Perindopril erbumine 4mg tablets
0205051M0AAABAB
|
Perindopril erbumine | Perindopril erbumine | Cardiovascular System | 221,811 |
|
Perindopril erbumine 2mg tablets
0205051M0AAAAAA
|
Perindopril erbumine | Perindopril erbumine | Cardiovascular System | 147,983 |
|
Perindopril erbumine 4mg/5ml oral solution
0205051M0AAAKAK
|
Perindopril erbumine | Perindopril erbumine | Cardiovascular System | 56 |
|
Perindopril erbumine 4mg/5ml oral suspension
0205051M0AAALAL
|
Perindopril erbumine | Perindopril erbumine | Cardiovascular System | 36 |
|
Perindopril erbumine 8mg/5ml oral liquid
0205051M0AAAHAH
|
Perindopril erbumine | Perindopril erbumine | Cardiovascular System | 7 |
|
Perindopril erbumine 1mg/5ml oral liquid
0205051M0AAACAC
|
Perindopril erbumine | Perindopril erbumine | Cardiovascular System | No data available |
|
Perindopril erbumine 2mg oral powder sachets
0205051M0AAAJAJ
|
Perindopril erbumine | Perindopril erbumine | Cardiovascular System | No data available |
|
Perindopril erbumine 2mg/5ml oral suspension
0205051M0AAADAD
|
Perindopril erbumine | Perindopril erbumine | Cardiovascular System | No data available |
|
Perindopril erbumine 3mg/5ml oral solution
0205051M0AAAMAM
|
Perindopril erbumine | Perindopril erbumine | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.